SCHEMBL7022249

SCHEMBL7022249

O=C(O)C1CN(C(=O)Oc2cccc3c2Cc2ccccc2-3)CCO1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.42
▸ HTR2A P28223 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ HRH1 P35367 1/20 0.39
▸ PDK1 Q15118 1/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.36
▸ POLB P06746 1/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ CASP3 P42574 1/20 0.35
▸ SENP7 Q9BQF6 1/20 0.35
▸ BCHE P06276 1/20 0.35
▸ GAA P10253 2/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ EPHX1 P07099 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7016808 0.89 PDK1 (0.43) TP53PDK1SMN1; SMN2POLBKMT2A
SCHEMBL7022253 0.87 TP53 (0.42) TP53HTR2AHTR2CHRH1PDK1
SCHEMBL7018475 0.84 TP53 (0.41) TP53PDK1SMN1; SMN2POLBKMT2A
SCHEMBL7016802 0.76 PDK1 (0.43) TP53HTR2APDK1SMN1; SMN2POLB
SCHEMBL30616301 0.72 RAB9A (0.49) HTR2AHTR2CSMN1; SMN2KMT2ANPC1
SCHEMBL14246787 0.72 SMN1; SMN2 (0.54) SMN1; SMN2POLBALDH1A1KDM4EL3MBTL1
SCHEMBL7018480 0.72 TP53 (0.41) TP53HTR2APDK1SMN1; SMN2POLB
SCHEMBL20886929 0.71 TOP1 (0.51) SMN1; SMN2POLBKMT2AGAANPC1
SCHEMBL8840922 0.70 RAB9A (0.54) HTR2AHTR2CSMN1; SMN2KMT2ABCHE
SCHEMBL1764043 0.70 PDK1 (0.45) TP53PDK1SMN1; SMN2POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 — — EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 — — US disclosed
EP-1194152-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-11-06 — — EP disclosed
EP-1206265-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-08-07 — — EP disclosed
EP-1206265-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 — — EP disclosed
EP-1194152-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-04-10 — — EP disclosed
US-6316444-B1 SRC kinase inhibitor compounds MERCK & CO., INC. 2001-11-13 — — US disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 — — WO disclosed
WO-2001000214-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 — — WO disclosed
Send feedback